125 related articles for article (PubMed ID: 29477364)
1. Ghrelin protects against depleted uranium-induced bone damage by increasing osteoprotegerin/RANKL ratio.
Hao Y; Gao R; Lu B; Ran Y; Yang Z; Liu J; Li R
Toxicol Appl Pharmacol; 2018 Mar; 343():62-70. PubMed ID: 29477364
[TBL] [Abstract][Full Text] [Related]
2. Ghrelin protects against depleted uranium-induced apoptosis of MC3T3-E1 cells through oxidative stress-mediated p38-mitogen-activated protein kinase pathway.
Hao Y; Liu C; Huang J; Gu Y; Li H; Yang Z; Liu J; Wang W; Li R
Toxicol Appl Pharmacol; 2016 Jan; 290():116-25. PubMed ID: 26529667
[TBL] [Abstract][Full Text] [Related]
3. Gu Ling Pian, a traditional Chinese medicine, regulates function and OPG/RANKL synthesis of osteoblasts via the p38 MAPK pathway.
Zhao Y; Li J; Liu Y; Yu KQ; Zhang J; Chen XG
J Pharm Pharmacol; 2007 Aug; 59(8):1167-73. PubMed ID: 17725861
[TBL] [Abstract][Full Text] [Related]
4. Metformin stimulates osteoprotegerin and reduces RANKL expression in osteoblasts and ovariectomized rats.
Mai QG; Zhang ZM; Xu S; Lu M; Zhou RP; Zhao L; Jia CH; Wen ZH; Jin DD; Bai XC
J Cell Biochem; 2011 Oct; 112(10):2902-9. PubMed ID: 21618594
[TBL] [Abstract][Full Text] [Related]
5. Homocysteine alters the osteoprotegerin/RANKL system in the osteoblast to promote bone loss: pivotal role of the redox regulator forkhead O1.
Vijayan V; Khandelwal M; Manglani K; Singh RR; Gupta S; Surolia A
Free Radic Biol Med; 2013 Aug; 61():72-84. PubMed ID: 23500899
[TBL] [Abstract][Full Text] [Related]
6. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin.
Peng S; Liu XS; Huang S; Li Z; Pan H; Zhen W; Luk KD; Guo XE; Lu WW
Bone; 2011 Dec; 49(6):1290-8. PubMed ID: 21925296
[TBL] [Abstract][Full Text] [Related]
7. Oral Exposure to ZnO Nanoparticles Disrupt the Structure of Bone in Young Rats via the OPG/RANK/RANKL/IGF-1 Pathway.
Xu X; Tang Y; Lang Y; Liu Y; Cheng W; Xu H; Liu Y
Int J Nanomedicine; 2020; 15():9657-9668. PubMed ID: 33299310
[TBL] [Abstract][Full Text] [Related]
8. Temporal and spatial expression of osteoprotegerin and receptor activator of nuclear factor -kappaB ligand during mandibular distraction in rats.
Zhu WQ; Wang X; Wang XX; Wang ZY
J Craniomaxillofac Surg; 2007 Mar; 35(2):103-11. PubMed ID: 17449257
[TBL] [Abstract][Full Text] [Related]
9. Increased RANK ligand in bone marrow of orchiectomized rats and prevention of their bone loss by the RANK ligand inhibitor osteoprotegerin.
Li X; Ominsky MS; Stolina M; Warmington KS; Geng Z; Niu QT; Asuncion FJ; Tan HL; Grisanti M; Dwyer D; Adamu S; Ke HZ; Simonet WS; Kostenuik PJ
Bone; 2009 Oct; 45(4):669-76. PubMed ID: 19539794
[TBL] [Abstract][Full Text] [Related]
10. Effects of 17β-estradiol on adiponectin regulation of the expression of osteoprotegerin and receptor activator of nuclear factor-κB ligand.
Wang QP; Yang L; Li XP; Xie H; Liao EY; Wang M; Luo XH
Bone; 2012 Sep; 51(3):515-23. PubMed ID: 22634178
[TBL] [Abstract][Full Text] [Related]
11. Prostate-specific antigen stimulates osteoprotegerin production and inhibits receptor activator of nuclear factor-kappaB ligand expression by human osteoblasts.
Yonou H; Horiguchi Y; Ohno Y; Namiki K; Yoshioka K; Ohori M; Hatano T; Tachibana M
Prostate; 2007 Jun; 67(8):840-8. PubMed ID: 17394194
[TBL] [Abstract][Full Text] [Related]
12. [Guling tablets promotes the proliferation and mineralization and regulates OPG/RANKL/M-CSF expression of osteoblasts via the p38 MAPK pathway in vitro].
Huang SH; Zhang J; Li J; Cai HB
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1148-50. PubMed ID: 18676248
[TBL] [Abstract][Full Text] [Related]
13. Calycosin attenuates osteoporosis and regulates the expression of OPG/RANKL in ovariectomized rats
Li N; Tu Y; Shen Y; Qin Y; Lei C; Liu X
Pharmazie; 2016 Oct; 71(10):607-612. PubMed ID: 29441931
[TBL] [Abstract][Full Text] [Related]
14. Prolactin decreases expression of Runx2, osteoprotegerin, and RANKL in primary osteoblasts derived from tibiae of adult female rats.
Charoenphandhu N; Teerapornpuntakit J; Methawasin M; Wongdee K; Thongchote K; Krishnamra N
Can J Physiol Pharmacol; 2008 May; 86(5):240-8. PubMed ID: 18432284
[TBL] [Abstract][Full Text] [Related]
15. Berberine alleviates oxidative stress in rats with osteoporosis through receptor activator of NF-kB/receptor activator of NF-kB ligand/osteoprotegerin (RANK/RANKL/OPG) pathway.
He XF; Zhang L; Zhang CH; Zhao CR; Li H; Zhang LF; Tian GF; Guo MF; Dai Z; Sui FG
Bosn J Basic Med Sci; 2017 Nov; 17(4):295-301. PubMed ID: 29055350
[TBL] [Abstract][Full Text] [Related]
16. [Effect of modified sijunzi decoction on the bone metabolism of adriamycin induced nephropathy rats].
Zheng J; Liu JL; Lin MF; Wang ZF; Liu CY; Wu XH; Lin HY; Chen CF; Zheng XM; Chen XY
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Oct; 33(10):1376-81. PubMed ID: 24432683
[TBL] [Abstract][Full Text] [Related]
17. Effects of pamidronate disodium on the loss of osteoarthritic subchondral bone and the expression of cartilaginous and subchondral osteoprotegerin and RANKL in rabbits.
Lv Y; Xia JY; Chen JY; Zhao H; Yan HC; Yang HS; Li Q; Fan YX; Guo KJ; Chen XY
BMC Musculoskelet Disord; 2014 Nov; 15():370. PubMed ID: 25377946
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the effects of genistein and zoledronic acid on the bone loss in OPG-deficient mice.
Liu J; Xu K; Wen G; Guo H; Li S; Wu X; Dai R; Sheng Z; Liao E
Bone; 2008 May; 42(5):950-9. PubMed ID: 18337202
[TBL] [Abstract][Full Text] [Related]
19. Prolactin directly enhances bone turnover by raising osteoblast-expressed receptor activator of nuclear factor kappaB ligand/osteoprotegerin ratio.
Seriwatanachai D; Thongchote K; Charoenphandhu N; Pandaranandaka J; Tudpor K; Teerapornpuntakit J; Suthiphongchai T; Krishnamra N
Bone; 2008 Mar; 42(3):535-46. PubMed ID: 18166509
[TBL] [Abstract][Full Text] [Related]
20. Treatment of OPG-deficient mice with WP9QY, a RANKL-binding peptide, recovers alveolar bone loss by suppressing osteoclastogenesis and enhancing osteoblastogenesis.
Ozaki Y; Koide M; Furuya Y; Ninomiya T; Yasuda H; Nakamura M; Kobayashi Y; Takahashi N; Yoshinari N; Udagawa N
PLoS One; 2017; 12(9):e0184904. PubMed ID: 28937990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
